In-vitro Biochemical Studies on Organometallic Compounds as Anticancer Agents

Main Article Content

F. Z. Mohammed
Elsherbiny H. Elsayed
Atef E. Abd Elbaky
H. M. Shalaby

Abstract

This study aims to synthesis of copper complexes of 2,3-dihydroxy benzaldehyde thiosemicarbazone (3a,b), followed by evaluating their in vitro anticancer properties. The prepared compounds have been also evaluated for their ability to induce apoptosis. A total number of 80 adult female Swiss albino mice weighing 20-25 gm were divided randomly into 8 groups (10 mice /each group). The in vitro cytotoxic activities of compounds (3a, 3b) were evaluated. Minimum inhibitory concentrations of synthesized compound 3a were found to be 50 μg/mL against MCF-7, HepG2 and PC3 cell lines; also, Minimum inhibitory concentrations of synthesized compound 3b were found to be 50 μg/mL in all cell lines. The apoptotic effect of compounds 3a and 3b were evaluated by measurement Caspase-3 activity and Bcl-2 concentration. The mean values of Caspase-3 activity in positive control were found to be 2.6151 (ng/mL). On the other hand, the mean values of Bcl-2 in positive control were found to be 3.7 (ng/mL). The compounds (3a & 3b) exhibited a significant anticancer activity towards MCF-7, HEPG2 and PC3 cancer cell lines.

Keywords:
In vitro anticancer properties, copper complexes, 2,3-dihydroxy benzaldehyde thiosemicarbazone, adult female Swiss albino mice, MCF-7, HepG2 and PC3 cell lines.

Article Details

How to Cite
Mohammed, F., Elsayed, E., Elbaky, A. E. A., & Shalaby, H. (2019). In-vitro Biochemical Studies on Organometallic Compounds as Anticancer Agents. Asian Journal of Research in Biochemistry, 5(1), 1-9. https://doi.org/10.9734/ajrb/2019/v5i130080
Section
Original Research Article

References

Mohammed FZ, EL-Deen IM, Tmamm AS. Biochemical studies on coumarin derivatives as antioxidant and antitumor agents. Asian Journal of Research in Biochemistry AJRB. 2019;9(2):48917.

Tomasetti C, Li L, Vogelstein B, et al. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science. 2017;355(6331):1330–1334.

Alain F. Genetics, epigenetics and cancer. Canc Therapy & Oncol Int J. 2017;4(2): 555-634.

Gasser G, Ott I, Nils Metzler-Nolte. Organometallic anticancer compounds. J. Med. Chem. 2011;54(3):252–253.

Zahran F, Keshta AT, EL-Deen IM, El-behary MM. Mode of action of potassium salt of 2-thioxo-4-hydroxycoumarin [3, 4-b] pyrimidine and 9-bromo-2-thioxo-hydroxy-coumarin [3, 4-b] pyrimidine against Ehrlich Ascites carcinoma cells. Biol. Chem. Res. 2014;76-89.

Zaki M, Hairat S, Aazam E. Scope of organometallic compounds based on transition metal-arene systems as anti-cancer agents: Starting from the classical paradigm to targeting multiple strategies; RSC Adv. 2019;9:3239-3278.

Thavasu W, Longhurst S, Joel P, Slevin L, Balkwill R. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods. 1992;153(1-2):115-124.

Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Jonathan T. Warren, Bokesch H, Kenney S, Boyd M. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute. 1990;82(13):4-8.

Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1:1112-1116.

Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J. Exp. Med. 1996;183:1957-1964.

Reed G, Poyner R, Larsen T, Wedekind J, Raymenta I. Structural and mechanistic studies of enolase, Current Opinion in Structural Biology. 1996;6(6):736-743.

Levesque R SPSS. Programming and data management: A guide for SPSS and SAS Users, Fourth Edition, SPSS Inc., Chicago Ill; 2007.

Hanahan D, Weinberg R. The hallmarks of cancer. Cell. 2011;100(6):57–70.

Helleday T, Petermann E, Lundin C, Hodgson B, Sharma A. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008;8(3):193-204.

Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. Curcumin (diferuloyl-methane) induces apoptosis through activation of caspase-8, BID cleavage, and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis. 2002;23:143–150.

Jakupec A, Galanski M, Arion V, Hartinger G, Keppler K. Antitumour metal com-pounds: More than theme and variations. Dalton Transactions. 2008;2:183-194.

Arora S, Agarwal S, Singhal S. Anticancer activities of thiosemicarbazides/ thiose-micarbazones. Int J Pharm Pharm Sci. 2014;6(9):34-41.

Koňariková K, Perdikaris G, Gbelcová H, Andrezálová L, Švéda M, Ruml T, Laubertová L, Režnáková S, Žitňanová I. Autophagy in MCF-7 cancer cells induced by copper complexes. Pharmacol Rep. 2016;68(6):1221-1224.

Liang C, Xia J, Lei D, Li X, Yao Q, Gao J. Synthesis, in vitro and in vivo antitumor activity of symmetrical bis-Schiff base derivatives of isatin. Eur J Med Chem. 2014;74(9):742-750.

Vyas A, Patitungkho S, Jamadar A, Adsule S, Padhyea S, Ahmad A. ATRA-hydrazonate derivatives and their copper complexes against hormone-dependent (MCF-7), hormoneindependent (MDA-MB-231 and BT-20) breast cancer and androgen-independent (PC3) prostate cancer cell lines. Inorg Chem Com. 2012; 23(11):17-20.

Francisco D, Peddi P, Hair J, Flood B, Cecil A, Kalogerinis P. Induction and processing of complex DNA damage in human breast cancer cells MCF-7 and nonmalignant MCF-10A cells. Free Rad Biol Med. 2009;44(4):558-69.

Karlsson H, Fryknäs M, Strese S, Gullbo J, Larsson R, Sjöblom T, Pandzic T, Nygren P, Westman G, Bremberg U. Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity. Oncotarget. 2017;8:30217–30234.